Sensus Healthcare, Inc. (SRTS) stock
SRTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 9/3041% below fair value
$2.26−0.08 (-3.42%)
Close on Nov 17, 2026Market cap $37.20MP/E –Yield –
Sensus Healthcare operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Sensus Healthcare's operating cash flow for the twelve months ending Sep 30, 2026 was -$11.35M, down 695.1% year over year. For fiscal 2025 it was $528.00K. The highest annual figure on record is $528.00K in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $528.00K | – |
| FY2024 | Dec 31, 2024 | -$831.00K | – |
| FY2023 | Dec 31, 2023 | -$2.15M | – |
| FY2022 | Dec 31, 2022 | -$1.41M | – |
| FY2021 | Dec 31, 2021 | -$286.00K | – |
| FY2020 | Dec 31, 2020 | -$434.00K | – |
| FY2019 | Dec 31, 2019 | -$2.11M | – |
| FY2018 | Dec 31, 2018 | -$8.56M | – |
| FY2017 | Dec 31, 2017 | -$3.06M | – |
| FY2016 | Dec 31, 2016 | -$851.02K | – |
| FY2015 | Dec 31, 2015 | -$1.34M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$2.26M | -198.5% |
| Q2 FY2026 | Jun 30, 2026 | -$3.13M | -200.5% |
| Q1 FY2026 | Mar 31, 2026 | -$3.75M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.21M | – |
| Q3 FY2025 | Sep 30, 2025 | $2.30M | -41.9% |
| Q2 FY2025 | Jun 30, 2025 | $3.12M | -26.3% |
| Q1 FY2025 | Mar 31, 2025 | -$2.68M | – |
| Q4 FY2024 | Dec 31, 2024 | -$827.00K | -131.0% |
| Q3 FY2024 | Sep 30, 2024 | $3.95M | +794.3% |
| Q2 FY2024 | Jun 30, 2024 | $4.23M | +470.1% |
| Q1 FY2024 | Mar 31, 2024 | -$8.19M | – |
| Q4 FY2023 | Dec 31, 2023 | $2.67M | – |
| Q3 FY2023 | Sep 30, 2023 | $442.00K | -88.1% |
| Q2 FY2023 | Jun 30, 2023 | $742.00K | -60.9% |
| Q1 FY2023 | Mar 31, 2023 | -$6.00M | -294.6% |
| Q4 FY2022 | Dec 31, 2022 | -$10.11M | – |
| Q3 FY2022 | Sep 30, 2022 | $3.72M | +197.1% |
| Q2 FY2022 | Jun 30, 2022 | $1.90M | +39.8% |
| Q1 FY2022 | Mar 31, 2022 | $3.08M | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.78M | – |
| Q3 FY2021 | Sep 30, 2021 | $1.25M | – |
| Q2 FY2021 | Jun 30, 2021 | $1.36M | -36.4% |
| Q1 FY2021 | Mar 31, 2021 | -$1.12M | -356.9% |
| Q4 FY2020 | Dec 31, 2020 | -$360.00K | -178.3% |
| Q3 FY2020 | Sep 30, 2020 | -$2.64M | – |
| Q2 FY2020 | Jun 30, 2020 | $2.13M | -65.5% |
| Q1 FY2020 | Mar 31, 2020 | $434.00K | – |
| Q4 FY2019 | Dec 31, 2019 | $459.93K | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.62M | – |
| Q2 FY2019 | Jun 30, 2019 | $6.18M | – |
| Q1 FY2019 | Mar 31, 2019 | -$7.12M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.65M | -307.9% |
| Q3 FY2018 | Sep 30, 2018 | -$2.22M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.21M | – |
| Q1 FY2018 | Mar 31, 2018 | -$3.48M | – |
| Q4 FY2017 | Dec 31, 2017 | $794.93K | -46.6% |
| Q3 FY2017 | Sep 30, 2017 | -$914.76K | – |
| Q2 FY2017 | Jun 30, 2017 | -$60.71K | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.88M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.49M | – |
See a number that looks wrong?